Nippon India Pharma Fund - Growth Plan - Growth Option-insured

Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Nippon India Pharma Fund - Growth Plan - Growth Option-insured
Rating
Fund
Time to Invest
Nippon India Pharma Fund - Growth Plan - Growth Option-insured
NAV
270.3261
(17/05/2022)
L 52Wk H
263.74
317.43
Login using to know what your Friends are Investing !

Nippon India Pharma Fund - Growth Plan - Growth Option-insured

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Nippon India Pharma Fund - Growth Plan - Growth Option-insured
Fund
NAV
270.3261
(17/05/2022)
Time to Invest
Nippon India Pharma Fund - Growth Plan - Growth Option-insured
Rating
L 52Wk H
263.74
317.43

Asset Allocation for Nippon India Pharma Fund - Growth Plan - Growth Option-insured Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Growth Plan - Growth Option-insured Fund Growth

69.71 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(13.98%)
Cipla LimitedCipla Limited(8.50%)
Divi's Laboratories LimitedDivi's Laboratories Limited(7.89%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(7.31%)
Lupin LimitedLupin Limited(6.60%)
Torrent Pharmaceuticals LimitedTorrent Pharmaceuticals Limited(6.14%)
Narayana Hrudayalaya LimitedNarayana Hrudayalaya Limited(5.98%)
Abbott India LimitedAbbott India Limited(5.02%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(4.54%)
Fortis Healthcare LimitedFortis Healthcare Limited(3.77%)

Detailed Portfolio of Nippon India Pharma Fund - Growth Plan - Growth Option-insured Fund Growth

Portfolio Date -30 Apr 2022
Equity Holdings -27
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 13.98% 678.005 Cr
Cipla Limited 8.50% 412.104 Cr
Divi's Laboratories Limited 7.89% 382.959 Cr
Dr. Reddy's Laboratories Limited 7.31% 354.553 Cr
Lupin Limited 6.60% 320.201 Cr
Torrent Pharmaceuticals Limited 6.14% 297.646 Cr
Narayana Hrudayalaya Limited 5.98% 290.006 Cr
Abbott India Limited 5.02% 243.450 Cr
Aurobindo Pharma Limited 4.54% 220.168 Cr
Fortis Healthcare Limited 3.77% 182.731 Cr
Apollo Hospitals Enterprise Limited 3.68% 178.518 Cr
Sanofi India Limited 3.31% 160.626 Cr
Gland Pharma Limited 3.30% 160.093 Cr
JB Chemicals & Pharmaceuticals Limited 3.00% 145.542 Cr
Thyrocare Technologies Limited 2.95% 143.192 Cr
Pfizer Limited 2.13% 103.067 Cr
Zydus Lifesciences Limited 1.81% 88.025 Cr
Indoco Remedies Limited 1.77% 85.937 Cr
Vijaya Diagnostic Centre Limited 1.68% 81.269 Cr -
Alkem Laboratories Limited 1.25% 60.751 Cr
IPCA Laboratories Limited 0.76% 36.715 Cr -
Orchid Pharma Limited 0.74% 35.970 Cr
Tarsons Products Limited 0.54% 26.385 Cr -
Ajanta Pharma Limited 0.54% 26.099 Cr
Jubilant Pharmova Limited 0.54% 25.957 Cr
Rainbow Childrens Medicare Limited 0.50% 24.240 Cr -
Healthcare Global Enterprises Limited 0.47% 22.567 Cr
Holdings % Weight Value Sahi Hai/Nahi
Net Current Assets 1.08% 52.380 Cr -
Triparty Repo 0.25% 12.119 Cr -
Cash Margin - CCIL 0.00% 0.051 Cr -

Insight on the composition of the Nippon India Pharma Fund - Growth Plan - Growth Option-insured Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option-insured

Style Box of the Nippon India Pharma Fund - Growth Plan - Growth Option-insured Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option-insured

Portfolio Characteristics of the Nippon India Pharma Fund - Growth Plan - Growth Option-insured Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option-insured